What is the current Branched Stent Grafts market size?

The Branched Stent Grafts market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Branched Stent Grafts market?

Key drivers include rising cases of aortic aneurysms and technological advancements in stent grafts.

What are the major challenges facing the market?

Challenges include high costs, limited reimbursement, and stringent regulatory approvals.

Which regions are leading the Branched Stent Grafts market?

North America and Europe are leading the market due to advanced healthcare infrastructure.

Who are the top companies in the Branched Stent Grafts market?

Top companies include Medtronic, Cook Medical, and Endologix, offering innovative stent graft solutions.

What future opportunities exist in the market?

Future opportunities include emerging markets and increasing adoption of minimally invasive procedures.

How is technology impacting the Branched Stent Grafts market?

Advances in materials and design are improving stent graft performance and patient outcomes.

What is the current regulatory landscape for the market?

The regulatory landscape is evolving, with a focus on ensuring safety and efficacy of stent grafts.

What is the future outlook for the Branched Stent Grafts market?

The future outlook is positive, with growing demand and advancements in technology driving growth.

Branched Stent Grafts Market Potential & Strategic Outlook 2033

Branched Stent Grafts by Application (Metallic Material, Biomaterials, Other), by Types (Metallic Material, Biomaterials, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $3973.1 million

CAGR: 3.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $3973.1 million

CAGR: 3.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Branched Stent Grafts Market Overview

The Branched Stent Grafts market refers to the industry involved in the development and deployment of branched stent grafts, which are medical devices used to treat aortic aneurysms and other vascular conditions. As the global population ages and the prevalence of cardiovascular diseases increases, the Branched Stent Grafts market size is expected to experience significant growth, with a projected market size of approximately $1.4 billion by 2026. The growth outlook for the Branched Stent Grafts market forecast is positive, driven by advancements in medical technology, increasing demand for minimally invasive procedures, and an expanding patient population, leading to a market forecast of $2.5 billion by 2033, with a compound annual growth rate (CAGR) of 6.5%. The scope of the industry encompasses the design, manufacture, and marketing of branched stent grafts, as well as related services and accessories.

Loading chart…

The Branched Stent Grafts market is shaped by several key forces, including technological advancements, regulatory approvals, and competitive intensity. The largest region for branched stent grafts is currently North America, while the fastest-growing region is expected to be the Asia-Pacific, driven by increasing healthcare expenditure and a growing patient population. As the industry continues to evolve, manufacturers and suppliers must navigate these complex forces to capitalize on emerging opportunities and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	3.97 billion
Revenue forecast in 2033	6.93 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Alvimedica; Eucatech AG; Abbott Laboratories; Cardinal Health; Terumo; Biotronik; Endocor GmbH; Merit Medical Systems; Cook Medical; Boston Scientific Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Branched Stent Grafts market is poised for significant growth, driven by factors such as increasing demand for minimally invasive procedures and advancements in technology. The growth forecast for the Branched Stent Grafts market size is expected to be substantial, with key players investing heavily in research and development to capitalize on emerging opportunities.

Growth Drivers2 items

Advances in stent graft technology are enabling the development of more sophisticated branched stent grafts, which are better suited to treat complex aortic aneurysms, thereby driving the Branched Stent Grafts market size.

The increasing prevalence of aortic aneurysms and the growing demand for minimally invasive procedures are contributing to the growth of the Branched Stent Grafts market, with the global market size expected to expand rapidly over the forecast period.

Restraints2 items

Stringent regulatory requirements and high development costs are hindering the growth of the Branched Stent Grafts market, as companies must navigate complex approval processes and invest heavily in clinical trials to bring new products to market.

The high cost of branched stent grafts and the limited reimbursement for these devices in certain regions are restricting their adoption, particularly in price-sensitive markets, and impacting the overall Branched Stent Grafts market size.

Opportunities2 items

The growing demand for customized stent grafts is creating new opportunities for companies to develop tailored solutions that meet the specific needs of patients, driving innovation and growth in the Branched Stent Grafts market.

The increasing focus on minimally invasive procedures is driving the adoption of branched stent grafts, as these devices offer a less invasive alternative to traditional open surgery, and companies are investing in research and development to capitalize on this trend and expand the Branched Stent Grafts market size.

Challenges2 items

The complexity of branched stent grafts poses significant challenges for manufacturers, as these devices require advanced design and manufacturing capabilities, and companies must balance innovation with regulatory compliance to ensure the growth forecast for the Branched Stent Grafts market is achieved.

The competitive landscape of the Branched Stent Grafts market is highly fragmented, with several key players competing for market share, and companies must develop effective strategies to differentiate their products and maintain a strong market position, impacting the overall Branched Stent Grafts market size and growth.

Market Segmentation

Loading chart…

The Application segment of the Branched Stent Grafts market is a crucial aspect of Branched Stent Grafts segmentation. This market can be broadly categorized based on its application in treating various aortic diseases, such as abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). The application segment contributes significantly to the overall Branched Stent Grafts market size, with a substantial portion of the revenue generated from the treatment of these conditions. Understanding the application segment is essential for market players to develop targeted strategies and products that cater to specific patient needs, ultimately driving the growth of the Branched Stent Grafts market.

The Types segment of the Branched Stent Grafts market includes subtypes such as [object Object] and [object Object], which are designed to treat specific types of aortic aneurysms. Each subtype has its own set of characteristics, advantages, and limitations, making them suitable for different patient populations. The types segment plays a vital role in the market taxonomy of Branched Stent Grafts, as it enables market players to differentiate their products and develop innovative solutions that address the unique needs of various patient groups. By analyzing the types segment, market players can identify opportunities to expand their product portfolios and improve patient outcomes.

Branched Stent Grafts Segmentation Breakdown8 items

Application

Metallic Material

Biomaterials

Other

Types

Metallic Material

Biomaterials

Other

Regional Insights

Loading chart…

The Branched Stent Grafts market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of branched stent grafts, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, high demographics of cardiovascular diseases, advanced infrastructure, and a mature ecosystem; for Europe, increasing adoption of minimally invasive procedures, favorable policies, and a strong ecosystem; for Asia Pacific, growing investments in healthcare, large demographics, and improving infrastructure; for Latin America, rising adoption of branched stent grafts, increasing investments in healthcare, and a developing ecosystem; and for Middle East & Africa, growing demographics, improving infrastructure, and increasing adoption of advanced medical technologies.

The regional forecast indicates that the Branched Stent Grafts market will experience significant growth in the coming years, driven by increasing demand for minimally invasive procedures and advances in medical technology. Understanding the key drivers and trends in each region is crucial for companies looking to expand their presence in the global Branched Stent Grafts market.

Competitive Landscape

The Branched Stent Grafts market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Branched Stent Grafts competitive landscape is driven by global players, including those with a strong presence in the medical devices industry. Key competitive levers include product innovation, with companies investing in research and development to improve device efficacy and safety, as well as distribution and pricing strategies to expand their market reach.

Companies in the Branched Stent Grafts market are employing various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and expansion into new regions. Common challenges faced by these companies include margin pressure, compliance costs, and supply chain risks. To stay competitive, companies are focusing on technological advancements, service model innovation, and channel strength, as well as customization and cost advantages. The following companies are notable for their strategic focus:

Medtronic: regional expansion

Alvimedica: innovation pipeline

Eucatech AG: local manufacturing

Abbott Laboratories: vertical integration

Cardinal Health: OEM tie-ups

Terumo: premium pricing

Key Branched Stent Grafts Companies11 items

Medtronic

Alvimedica

Eucatech AG

Abbott Laboratories

Cardinal Health

Terumo

Biotronik

Endocor GmbH

Merit Medical Systems

Cook Medical

Boston Scientific Corporation

Market Ecosystem

The Branched Stent Grafts ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and manufacturers, to downstream channels and end users. Value is created and captured through the development, production, and distribution of branched stent grafts, with each participant playing a distinct role in the value chain analysis. Understanding the boundaries and interactions within this ecosystem is crucial for navigating the market.

Raw material suppliers — providing biomaterials and metals

OEMs / manufacturers — designing and producing stent grafts

Technology providers — developing innovative stent graft technologies

System integrators / EPCs — integrating stent grafts into treatment solutions

Distributors / channel partners — delivering products to healthcare facilities

Regulators/standards bodies — overseeing safety and efficacy standards

End users / buyers — healthcare professionals and patients

The flow of value within the Branched Stent Grafts ecosystem is influenced by various control points, including regulatory approvals and reimbursement policies. Dependency risks, such as input constraints and standards compliance, can impact the availability and adoption of branched stent grafts. Moreover, switching costs, partnerships, and interoperability requirements can affect the relationships between ecosystem participants. The ecosystem's dynamics can differ by region, with varying regulatory frameworks, healthcare systems, and market needs influencing the interactions and value capture among participants.

Recent Industry Insights

The Branched Stent Grafts industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key market players have focused on enhancing product portfolios and expanding global reach. Notably, several mergers and acquisitions have taken place, leading to market consolidation and increased competition. Furthermore, there have been several product launches, including advanced stent graft systems with improved durability and efficacy. Regulatory changes, such as updated guidelines for clinical trials, have also impacted the industry. A shift in consumer trends towards minimally invasive procedures has driven demand for branched stent grafts, with companies responding through funding rounds and expansions to meet this growing need.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Branched Stent Grafts market. The market attractiveness of Branched Stent Grafts is significant, driven by increasing demand for minimally invasive procedures and advancements in medical technology. The competitive intensity is moderate, with key players investing in research and development to improve product offerings. The long-term Branched Stent Grafts market outlook is promising, with opportunities for growth in emerging markets and expanding applications.

The innovation landscape is characterized by ongoing research in materials and design, aiming to enhance durability and efficacy. The demand–supply balance is relatively stable, with manufacturers working to meet growing demand. However, key risk factors include regulatory challenges and potential supply chain disruptions. Overall, the Branched Stent Grafts market presents opportunities for growth and innovation, driven by advancing technology and increasing patient needs.

11 items

1. Executive Summary

2. Branched Stent Grafts Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Branched Stent Grafts Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Branched Stent Grafts Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Metallic Material

6.1.2. Biomaterials

6.1.3. Other

6.2. Global Branched Stent Grafts Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Metallic Material

6.2.2. Biomaterials

6.2.3. Other

6.3. Global Branched Stent Grafts Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Branched Stent Grafts Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Branched Stent Grafts Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Branched Stent Grafts Market Competition by Key Manufacturers

8.1. Global Branched Stent Grafts Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Branched Stent Grafts: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Alvimedica

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Eucatech AG

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abbott Laboratories

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cardinal Health

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Terumo

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Biotronik

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Endocor GmbH

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Merit Medical Systems

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cook Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Boston Scientific Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Branched Stent Grafts Market

Figure 4: Global Branched Stent Grafts Market: Drivers

Figure 5: Global Branched Stent Grafts Market: Challenges

Figure 6: Global Branched Stent Grafts Market: Trends

Figure 7: Global Branched Stent Grafts Market: Opportunity

Figure 8: Global Branched Stent Grafts Market: Restraint

Figure 9: Global Branched Stent Grafts Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Branched Stent Grafts Market Value (USD Million) By Region

Figure 15: Global Branched Stent Grafts Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Branched Stent Grafts Market Value (USD Million) By Region

Figure 23: Global Branched Stent Grafts Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Branched Stent Grafts Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Branched Stent Grafts Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Branched Stent Grafts Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Branched Stent Grafts Market Value (USD Million) By Region

Table 10: Global Branched Stent Grafts Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Branched Stent Grafts Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Branched Stent Grafts Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Branched Stent Grafts Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Alvimedica Basic Information And Sales Area

Table 33: Alvimedica. Products Portfolio

Table 34: Eucatech AG Basic Information And Sales Area

Table 35: Eucatech AG. Products Portfolio

Table 36: Abbott Laboratories Basic Information And Sales Area

Table 37: Abbott Laboratories. Products Portfolio

Table 38: Cardinal Health Basic Information And Sales Area

Table 39: Cardinal Health. Products Portfolio

Table 40: Terumo Basic Information And Sales Area

Table 41: Terumo. Products Portfolio

Table 42: Biotronik Basic Information And Sales Area

Table 43: Biotronik. Products Portfolio

Table 44: Endocor GmbH Basic Information And Sales Area

Table 45: Endocor GmbH. Products Portfolio

Table 46: Merit Medical Systems Basic Information And Sales Area

Table 47: Merit Medical Systems. Products Portfolio

Table 48: Cook Medical Basic Information And Sales Area

Table 49: Cook Medical. Products Portfolio

Table 50: Boston Scientific Corporation Basic Information And Sales Area

Table 51: Boston Scientific Corporation. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Branched Stent Grafts Market Value (USD Million) By Region

Table 57: Global Branched Stent Grafts Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Branched Stent Grafts Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.97 billion
Revenue forecast in 2033	6.93 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Alvimedica; Eucatech AG; Abbott Laboratories; Cardinal Health; Terumo; Biotronik; Endocor GmbH; Merit Medical Systems; Cook Medical; Boston Scientific Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Branched Stent Grafts Segmentation Breakdown8 items

Application

Metallic Material

Biomaterials

Other

Types

Metallic Material

Biomaterials

Other

Regional Insights

Loading chart…

Competitive Landscape

Medtronic: regional expansion

Alvimedica: innovation pipeline

Eucatech AG: local manufacturing

Abbott Laboratories: vertical integration

Cardinal Health: OEM tie-ups

Terumo: premium pricing

Key Branched Stent Grafts Companies11 items

Medtronic

Alvimedica

Eucatech AG

Abbott Laboratories

Cardinal Health

Terumo

Biotronik

Endocor GmbH

Merit Medical Systems

Cook Medical

Boston Scientific Corporation

Market Ecosystem

Raw material suppliers — providing biomaterials and metals

OEMs / manufacturers — designing and producing stent grafts

Technology providers — developing innovative stent graft technologies

System integrators / EPCs — integrating stent grafts into treatment solutions

Distributors / channel partners — delivering products to healthcare facilities

Regulators/standards bodies — overseeing safety and efficacy standards

End users / buyers — healthcare professionals and patients

Recent Industry Insights

Analyst Overview

Table of Contents